Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Originally developed for managing type 2 diabetes, this powerful GLP-1 receptor agonist has shown incredible results in helping people shed pounds
Satisfaction rating from patient experience survey results collected May 2025
In SURMOUNT-1, tirzepatide at 515 mg once weekly produced even greater average weight loss in adults with obesity.[2] By contrast, structured research on true microdosing regimens is limited
The Swissmedic laboratory found an impurity in one sample that could trigger hypersensitivity reactions in sensitive individuals
About 71 percent of the savings are returned to HCPF
US$ 22.46
US$ 24.90
US$ 21.77
